CANCER, published by Wiley, stands as a pivotal journal in the field of oncology and cancer research, boasting an impressive impact factor and consistently dynamic growth since its inception in 1948. With an ISSN of 0008-543X and an E-ISSN of 1097-0142, this esteemed journal is recognized for its rigorous peer-reviewed articles, making significant contributions to the understanding of cancer biology, treatment modalities, and clinical practices. CANCER holds a distinguished position in the academic community, securing its placement in the Q1 category for both cancer research and oncology, and ranks within the top percentiles on Scopus, indicating its high impact and relevance. The journal is particularly beneficial for researchers, professionals, and students seeking to stay abreast of the latest advancements in cancer science. By addressing essential research questions and providing pathways for new therapies, CANCER continues to play a crucial role in shaping the future of oncology and improving patient outcomes.

CA: A Cancer Journal for Clinicians is a prestigious academic journal published by Wiley, serving as a leading source of evidence-based information for those in the fields of oncology and hematology. With an impressive impact factor and ranked in the top quartile (Q1) for both specialties, this journal aims to bridge the gap between the latest research findings and clinical practice. Established in 1950, it boasts a long-standing history of delivering essential insights, guidelines, and innovative strategies to healthcare professionals worldwide, making significant contributions to the understanding and treatment of cancer. Although it does not offer open access, its published content is crucial for researchers, clinicians, and students dedicated to advancing cancer care. The journal's commitment to excellence is reflected in its elite rankings, holding the #1 position in both the Medicine – Oncology and Medicine – Hematology categories according to Scopus, positioning it in the 99th percentile of scholarly impact.

Seminars in Oncology Nursing, published by Elsevier Science Inc, serves as a cornerstone for the field of oncology nursing, facilitating the dissemination of high-quality research and clinical practice insights since 1985. This quarterly journal, with significant impact as reflected in its Q2 ranking in the Nursing category for Oncology, provides an essential platform for the authors to share their findings, experiences, and innovations that can enhance patient care in oncology settings. With its ISSN 0749-2081 and E-ISSN 1878-3449, the journal offers a comprehensive access to a wealth of articles that emphasize evidence-based practices, care models, and the evolving challenges faced by oncology nurses. Targeted towards researchers, clinicians, and students, Seminars in Oncology Nursing not only contributes to academic discourse but also supports the professional development of its readership, ultimately advancing the field of oncology nursing.

The Journal of Gerontological Nursing, published by SLACK INC, is a leading peer-reviewed journal dedicated to advancing the field of gerontological nursing through innovative research, clinical practice, and educational advancements. Since its inception in 1975, this journal has become a crucial resource for researchers, healthcare professionals, and students interested in the care and management of older adults. With an impact factor that reflects its significance within the disciplines of gerontology and nursing (Category Quartiles: Q3 in Gerontology and Q3 in Nursing), it serves as a platform for disseminating vital findings, best practices, and evidence-based approaches aimed at improving the quality of life for the aging population. While the journal maintains a print-only format, its content is invaluable for those looking to stay ahead in the rapidly evolving landscape of gerontological care. As it continues to publish until 2024, the Journal of Gerontological Nursing invites contributions that foster dialogue and innovation within this essential area of healthcare.

JNCI-Journal of the National Cancer Institute, published by Oxford University Press Inc. in the United Kingdom, is a premier journal dedicated to advancing the field of cancer research and oncology. With a distinguished history dating back to 1940, this journal has consistently maintained a strong reputation within the academic community, achieving a remarkable Q1 ranking in both Cancer Research and Oncology as of 2023. Researchers and practitioners rely on the JNCI for original research articles, review papers, and cutting-edge findings that impact clinical practices and therapeutic strategies. Although it does not currently offer open access, the journal remains a vital resource for academicians and healthcare professionals seeking to enhance their understanding of cancer mechanisms and treatment innovations. Its rigorous peer-review process ensures the publication of high-quality, credible research that meets the evolving challenges of cancer treatment and prevention through to 2024.

eCancerMedicalScience, a leading open-access journal published by the eCancer Global Foundation, is dedicated to advancing the field of cancer research and oncology. With its inception in 2007, this esteemed journal has emerged as a pivotal platform for disseminating groundbreaking research, innovative treatments, and comprehensive reviews in the cancer domain. Based in the United Kingdom, eCancerMedicalScience has continuously contributed to the academic community with its rigorous peer-review process and broad-ranging scope, now encompassing topics from clinical oncology to molecular biology. Currently ranked in the Q3 quartile for both Cancer Research and Oncology in 2023, the journal provides a significant opportunity for researchers, professionals, and students to access valuable insights and share their findings within a global network. The commitment to open access ensures that knowledge is readily available, fostering collaborative efforts to combat cancer and improve patient outcomes.

Psycho-Oncologie is a specialized academic journal dedicated to the intersection of psychology and oncology, published by TECH SCIENCE PRESS. With an ISSN of 1778-3798 and E-ISSN of 1778-381X, this journal serves as an important platform for researchers and practitioners seeking to understand the psychological impact of cancer on patients and their families. Established in 2007 and converging with its findings through 2024, Psycho-Oncologie aims to disseminate high-quality research that enhances mental health and promotes effective treatment strategies within the oncological landscape. Although currently holding a Q4 ranking in disciplines such as Clinical Psychology and Oncology, the journal is committed to maintaining a high standard of research integrity and scientific rigor to foster future advancements. Although it operates under a non-open access model, the journal strives to make its valuable insights available to a broader audience. For those in the fields of psychology, oncology, and health care, Psycho-Oncologie is an essential resource for staying abreast of critical developments and contributing to interdisciplinary approaches in cancer treatment.

The GERONTOLOGIST, published by Oxford University Press Inc, is a premier journal in the field of geriatrics and gerontology, with a distinguished history since its inception in 1961. This esteemed journal stands out with its impressive Q1 rankings in prominent categories, including Geriatrics and Gerontology, reflecting its vital role in disseminating innovative research and advancing knowledge within these critical disciplines. With an impact factor that ranks it among the top journals in both Nursing Gerontology and Medicine, the GERONTOLOGIST serves as a key resource for researchers, professionals, and students dedicated to enhancing the health and well-being of older adults. Although it operates under a traditional access model, the journal remains committed to publishing cutting-edge studies that address the complexities of aging and inform evidence-based practices. By fostering a rich dialogue among scholars and practitioners, the GERONTOLOGIST is instrumental in shaping the future of gerontological research and policy.

PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, published by GEORG THIEME VERLAG KG, is a distinguished peer-reviewed journal focused on the interdisciplinary fields of psychotherapy, psychosomatics, and medical psychology. Since its inception in 1980, this journal has emerged as a significant platform for researchers and professionals to disseminate findings that bridge psychological theory and clinical practice, significantly contributing to the advancement of applied psychology, clinical psychology, and psychiatry. With an ongoing convergence of research until 2024, the journal maintains a vital role in its field, holding a Q3 ranking in multiple categories as of 2023, reflecting its relevance and quality within the academic community. Though not an open-access journal, it provides crucial insights that influence both scholarly discourse and clinical methodologies, making it an essential resource for anyone engaged in understanding the complexities of mental health and psychosomatic conditions.

JNCI Cancer Spectrum, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. With an impressive impact demonstrated through its Q1 ranking in both Cancer Research and Oncology categories for 2023, this journal provides a vital platform for disseminating high-quality research and innovative findings in a rapidly evolving landscape. Since its inception in 2017, JNCI Cancer Spectrum has embraced open access, enhancing the accessibility of evidence-based knowledge to researchers, professionals, and students across the globe. Additionally, it boasts notable positions in Scopus rankings, with a strong performance in both the Medicine and Biochemistry, Genetics and Molecular Biology categories. The journal is committed to its objectives of fostering collaborative efforts and encouraging dialogue among experts, making it an essential resource for anyone involved in cancer research.